David Bench - Feb 11, 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role: Chief Financial Officer
Signature: /s/ David Bench
Stock symbol: ENZ
Transactions as of: Feb 11, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/15/2022, 08:38 PM
Next filing: Mar 28, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ENZ	Common Stock, $0.01 Par Value						1.3K	Feb 11, 2022	401k	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENZ	Stock Option (to acquire Common Stock)	Award	$0	+87.5K		$0.00	87.5K	Feb 11, 2022	Common Stock	87.5K	$3.36	Direct	F2
holding	ENZ	Stock Option (to acquire Common Stock)						55.4K	Feb 11, 2022	Common Stock	55.4K	$2.63	Direct	F2
holding	ENZ	Stock Option (to acquire Common Stock)						55.4K	Feb 11, 2022	Common Stock	55.4K	$2.20	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted shares granted subject the Company's discretionary matching contribution and non-elective employer contribution which vest ratable over four years of service, which began on December 23, 2019.
F2	The stock options have a three-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.